The obesity associated FTO gene variant and the risk of adverse pregnancy outcomes: Evidence from the SCOPE study

Prabha H. Andraweera, Gustaaf A. Dekker, Shalem Leemaqz, Lesley McCowan, Claire T. Roberts, SCOPE consortium

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

Objective: To investigate whether the FTO rs9939609 single nucleotide polymorphism (SNP), which is a risk factor for obesity and vascular diseases, is also associated with pregnancy complications including pre-eclampsia, gestational hypertension, small for gestational age pregnancy (SGA), and spontaneous preterm birth (sPTB). Methods: A case-control study of 1,741 nulliparous Caucasian women, their partners, and infants was conducted. DNA was extracted from peripheral blood or saliva from parents and cord blood from infants and genotyped using the Sequenom MassARRAY system. Results: The prevalence of maternal and infant AA genotype of FTO rs9939609 was increased in the SGA group compared with the uncomplicated pregnancy group (19.2% vs. 13.4%, OR = 1.7, 95% CI = 1.1-2.6, P = 0.02 and 24.6% vs. 12.5%, OR = 2.7, 95% CI = 1.6-4.6, P = 0.0002). The prevalence of maternal and infant AA genotype of FTO rs9939609 was also increased in the sPTB group compared with the uncomplicated pregnancy group (20.8% vs. 13.4%, OR = 2.1, 95% CI = 1.2-3.8, P = 0.009 and 20.0% vs. 12.5%, OR = 2.4, 95% CI = 1.0-5.3, P = 0.03). Conclusions: The maternal and infant AA genotype of the obesity associated FTO rs9939609 SNP associates with increased risk for SGA and sPTB. This SNP may be important in predicting the risk of these pregnancy complications and subsequent vascular diseases.

Original languageEnglish
Pages (from-to)2600-2607
Number of pages8
JournalObesity
Volume24
Issue number12
Early online date28 Nov 2016
DOIs
Publication statusPublished - Dec 2016
Externally publishedYes

Keywords

  • obesity
  • maternal obesity
  • hypertension
  • type 2 diabetes
  • metabolic syndrome
  • pregnancy complications

Fingerprint Dive into the research topics of 'The obesity associated FTO gene variant and the risk of adverse pregnancy outcomes: Evidence from the SCOPE study'. Together they form a unique fingerprint.

Cite this